ema

News

EMA finds possible link between mRNA COVID jabs and myocardi...

The EU medicines regulator has said that there is some evidence to suggest a possible link between mRNA-based vaccines for COVID-19 and rare cases of heart inflammation.

News

EU okays BMS' azacitidine pill for first-line maintenance of...

Bristol-Myers Squibb has been granted EU approval for Onureg (azacitidine), a tablet form of an intravenous drug that has been mainstay of acute myeloid leukaemia (AML) therapy for more tha

News

J&J must ditch 60m COVID jabs made at US plant, but 10m are ...

The failings at a Baltimore, US factory making Johnson & Johnson's COVID-19 vaccine mean that millions of doses of the shot will have to be jettisoned, according to an FDA update.

Views & Analysis

How will NICE fare in a post-Brexit world?

NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU?

News

scientifically visualization of a coronavirus spike protein

EU starts rolling review of GSK's antibody for COVID-19

The EMA has begun a rolling review of a COVID-19 antibody developed by GlaxoSmithKline and Vir BioTech which could become the fourth drug of its type cleared for early use in the EU.

News

Calliditas eyes 2022 approval in EU for rare kidney disease ...

Calliditas Therapeutics is on course to launch its first product, Nefecon for rare disease primary IgA nephropathy (IgAN), in the first half of 2022 after getting the green light for an acc

EMA finds possible link between mRNA COVID jabs and myocardi...

EU okays BMS' azacitidine pill for first-line maintenance of...

J&J must ditch 60m COVID jabs made at US plant, but 10m are ...

How will NICE fare in a post-Brexit world?

EU starts rolling review of GSK's antibody for COVID-19

Calliditas eyes 2022 approval in EU for rare kidney disease ...

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

ema

Editor's Picks